Anesthesia, General
Anesthesia, Local
Hypnosis
Midazolam
Status Epilepticus

Midazolam

Midazolam is a short-acting benzodiazepine frequently used for anesthesia induction, seizure management, and procedural sedation. The water-soluble formulation allows for rapid onset and flexible administration routes, including intravenous and intramuscular, making it suitable for managing status epilepticus when intravenous access is limited. Midazolam also provides anxiolysis and hypnosis during the maintenance phase of general anesthesia and serves as an adjunct to regional and local anesthesia in various diagnostic and therapeutic procedures. This activity reviews the pharmacologic profile of midazolam, including its mechanism of action, onset, metabolism, and duration. Adverse event risks, including respiratory depression, hypotension, and paradoxical reactions, are discussed alongside appropriate monitoring parameters and strategies for minimizing complications. Relevant drug interactions and dose considerations are outlined across various clinical scenarios to support evidence-based decision-making. Emphasis is placed on the interprofessional team’s role in administering midazolam safely and effectively to improve patient outcomes across emergency, perioperative, and procedural care settings.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.